PDCD1 and neoplasm: Thus, the use of anti-PD-1 therapy appears paradoxical: on the one hand, anti-PD-1 therapy can provide an anti-tumor response by the immune system activation, and on the other hand, anti-PD-1 therapy can provide a pro-tumor response by increasing the proliferation of tumor cells.